Ocular Genomics
243 Charles Street Boston, MA 02114 Contact us
Diagnostic Testing
Support our research
Explore our labs
Ocular Genomics MENU
Ocular Genomics
  • Meet the Team
  • Services
    • Biobank Core Services
    • Bioinformatics and Statistics Core
    • Functional Genomics (Zebrafish) Core
    • Gene Transfer Vector
      • Rates
      • Order Information
      • Contact Us
    • Genetic Diagnostic Testing Service
      • Pricing
    • Genomics Core Services
      • Sample Processing
      • Sequencing
      • Other Genomics Services
    • IRD service
  • Labs
    • Amamoto lab
      • Lab Members
    • Biobank Core
    • Bujakowska Lab
      • Lab Members
      • Publications
    • Comander Lab
      • Lab Members
      • Publications
    • Engle Lab
    • Functional Genomics Core (Zebrafish Facility)
      • Lab Members
    • Genetic Counseling Team
      • Team Members
    • Genomics Core Lab
      • Lab Members
    • iPS Research Lab
      • Lab Members
      • Grant support
      • Publications
    • Liu Lab
      • Lab Members
      • Publications
      • Projects
    • Mary Whitman Lab
      • Lab Members
    • MEEI Bioinformatics Center (MBC)
      • Lab Members
    • Pierce Lab
      • Lab Members
      • Publications
      • Projects
    • Segrè Lab
      • Selected Publications
    • Vandenberghe Lab
      • Lab Members
    • Wiggs Lab
      • Lab Members
  • News & Publications
    • RETINAL Transcriptome
  • Affiliates
  • Careers
  • Home
  • News
  • OGI Partners with Agilent

Recent Posts

  • Francesca Kim wins ARVO outstanding poster award
  • Friedenwald Award Lecture presented by OGI member Connie Cepko at ARVO 2025 annual meeting
  • Findings highlight the significance of Vascular Endothelial Protein Tyrosine Phosphatase in diverse ocular and systemic veno-vascular diseases.
  • Extracellular Vesicle RNAs as Biomarkers for Inherited Retinal Degenerations
  • BRILLIANCE Trial shows CRISPR Gene Editing Found Safe and Effective for Treating Patients with rare genetic disorder.

Archives

  • May 2025
  • March 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • July 2024
  • June 2024
  • May 2024
  • January 2024
  • October 2023
  • July 2023
  • June 2023
  • May 2023
  • March 2023
  • February 2023
  • December 2022
  • November 2022
  • June 2021
  • May 2021
  • March 2021
  • February 2021
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • June 2020
  • August 2019
  • May 2019
  • April 2019
  • May 2018
  • April 2018
  • March 2018
  • November 2017
  • September 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017

Categories

  • News
  • Publication

OGI Partners with Agilent
May 1, 2017

MEEI Named by Agilent Technologies as Certified Service Provider for Next-Generation Sequencing and aCGH Solutions

SANTA CLARA, Calif., Oct. 24, 2013 – Agilent Technologies Inc. (NYSE: A) today announced that the Massachusetts Eye and Ear Infirmary, an affiliate of Harvard Medical School, has been authorized as a Certified Service Provider of Agilent’s next-generation target enrichment and microarray-based comparative genomic hybridization (aCGH) solutions. MEEI is home to the medical school’s Department of Ophthalmology Ocular Genomics Institute, which is working to harness the power of genomics and gene therapy to advance the knowledge and treatment of blinding eye diseases.

“Becoming an Agilent CSP enables us to provide the ocular genomics research community with access to the latest protocols and technologies we are using at Mass. Eye and Ear with ever-increasing success,” said Dr. Eric Pierce, director of the Ocular Genomics Institute. “It is our hope that these tools will help advance studies in genomic research and gene therapy. In addition, incorporating the Agilent Bravo Automated Liquid Handling platform into our service offerings will enable us to quickly process large volumes of samples for even more researchers and for a wide range of genomics applications. We are using these approaches to provide improved clinical genetic diagnostic testing services for patients with inherited eye disorders.”

“We are excited to have MEEI as part of the Agilent CSP program,” said Victor Fung, senior director of marketing for Agilent’s Genomics Solutions Division. “MEEI has used Agilent’s NGS target enrichment and aCGH solutions for several years in their retinal degeneration mutational disease research. We look forward to supporting them as they expand their services outside of the Harvard community.”

About the Agilent Certified Service Provider Program

Agilent offers its CSP program to select service provider laboratories interested in using its market-leading technologies to provide the highest-quality analysis services to their customers. The company offers two certification paths: Agilent’s CGH microarray platform and its upstream target enrichment next-generation sequencing platform. Hands-on training is also provided by field application scientists to ensure customers receive consistent data quality, reproducibility and reliability.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company’s 20,500 employees serve customers in more than 100 countries. Agilent had revenues of $6.9 billion in fiscal 2012. Information about Agilent is available at www.agilent.com.

NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available at www.agilent.com/go/news.

EDITORIAL CONTACT: Susan Berg

+1 408 553 7093

susan_berg1@agilent.com

Featured:

Contact Us

243 Charles Street
Boston, MA 02114

Labs

  • Amamoto lab
  • Biobank Core
  • Bujakowska Lab
  • Comander Lab
  • Engle Lab
  • Functional Genomics Core (Zebrafish Facility)
  • Genetic Counseling Team
  • Genomics Core Lab
  • iPS Research Lab
  • Liu Lab
  • Pierce Lab
  • Segrè Lab
  • Vandenberghe Lab
  • Whitman Lab
  • Wiggs Lab

Sitemap

  • Affiliates
  • Careers
  • Meet the Team
  • News & publications
  • Support Our Research
  • Services
  • Privacy
website-boston WebsiteBoston